$0.95
0.11%
NYSE, Sep 15, 09:30 am EDT.
ISIN
KYG393421030
Symbol
CORBF

Global Cord Blood Corporation Stock price

$0.95
+0.00 0.00% 1M
-0.10 9.43% 6M
+0.00 0.11% YTD
-0.05 4.90% 1Y
-0.79 45.34% 3Y
-3.65 79.33% 5Y
-4.40 82.22% 10Y
-4.55 82.71% 20Y
NYSE, Closing price Wed, Sep 16 2026
+0.00 0.00%
ISIN
KYG393421030
Symbol
CORBF

Is Global Cord Blood Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
$127.4m
Enterprise Value
$-865.9m
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
1.6
P/S
0.7 | -
EV/Sales
negative | -
EV/FCF
negative
P/B
0.2
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
- | -
Increased
0 Years
Financials (TTM | estimate)
Revenue
- | -
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
-
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
Financial Health
Equity Ratio
57.2%
Return on Equity
10.3%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
-
FCF per Share
-
Short interest
2.1%
Employees
1k
Rev per Employee
$150.0k

Global Cord Blood Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Global Cord Blood Corporation forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Global Cord Blood Corporation forecast:

Buy
89%
Hold
11%

Financial data from Global Cord Blood Corporation

Mar '22
+/-
%
185 185
7% 7%
100%
- Direct Costs 27 27
2% 2%
15%
158 158
8% 8%
85%
- Selling and Administrative Expenses 64 64
4% 4%
34%
- Research and Development Expense 3.33 3.33
6% 6%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 91 91
12% 12%
49%
Net Profit 75 75
1% 1%
40%

In millions USD.

Don't miss a Thing! We will send you all news about Global Cord Blood Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

Head office Cayman Islands
CEO Ms. Zheng
Employees 1,202
Founded 2008
Website globalcordbloodcorporation.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today